Results 131 to 140 of about 1,629 (148)

Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review

Journal of Oncology Pharmacy Practice, 2021
Yazan Samhouri, Salman Fazal
exaly  

More on Blastic Plasmacytoid Dendritic-Cell Neoplasms

New England Journal of Medicine, 2019
Jean-Baptiste, Micol, Sylvain, Pilorge, David, Ghez   +2 more
openaire   +4 more sources

<p>Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data</p>

OncoTargets and Therapy, 2020
Guillaume Béziat, Loïc Ysebaert
exaly  

Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Expert Opinion on Biological Therapy, 2020
Mansour Alfayez, Naveen Pemmaraju, Marina Konopleva   +2 more
exaly  

Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies

Biology of Blood and Marrow Transplantation, 2016
Jonathan Farhi, Kamel Laribi, Pierre Lemaire   +2 more
exaly  

Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm

Hematology/Oncology Clinics of North America, 2020
Stefano Pileri, Maria Rosaria Sapienza
exaly  

Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?

British Journal of Dermatology, 2010
Laurent Machet, Marie Beylot-Barry, Eve Maubec   +2 more
exaly  

Morphologic Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report

Ultrastructural Pathology, 2014
Yingchang Mi, Shuxu Dong
exaly  

Blastic Plasmacytoid Dendritic Cell Neoplasm

2017
Facchetti F., Fisogni S.
openaire   +3 more sources

A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm

Critical Reviews in Oncology/Hematology, 2016
Hassan Sibai, Uday Deotare, Umberto Falcone   +2 more
exaly